Advancing risk stratification for DSP cardiomyopathy with postmortem genetic testing

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Both DSP cardiomyopathy and plakophilin 2 are associated with arrhythmogenic right ventricular cardiomyopathies via a desmosomal mechanism.

Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more

Rise and shine, everyone, another busy day is on the way. Moreover, this is shaping up to be a sunny one, as well. This is

March 7, 2024

Semaglutide’s Weight-Loss Benefit Also Seen in Patients on Antidepressants

DALLAS — People taking antidepressants lost a similar amount of weight on semaglutide 2.4 mg (Wegovy) compared with those not taking antidepressants, according to a

October 17, 2023

Park runs boost life satisfaction and save money by improving well-being

Park runs improve life satisfaction, especially for the least active, while providing significant economic benefits through cost-effectiveness.

October 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.